In July 2017, I obtained a Master’s degree in Bio-Pharmaceutical Sciences at Leiden University. During my master, I worked as a research intern in the group of Bob van de Water where I focused on breast cancer cell migration. For a second intern, I went to the Netherlands Cancer Institute to identify molecular mechanisms responsible for resistance to prostate cancer treatments. In April 2018, I joined the group of Bob van de Water again to work as a research technician on hepatotoxicity related projects.
- Leiden Academic Centre for Drug Research
- Braak B. ter, Niemeijer M., Wolters L., Le Dévédec S., Bouwman P. & Water B. van de (2021), Towards an advanced testing strategy for genotoxicity using image-based 2D and 3D HepG2 DNA damage response fluorescent protein reporters, Mutagenesis .
- Koedoot E., Wolters L., Smid M., Stoilov P., Burger G.A., Herpers B.H.A., Yan K., Price L.S., Martens J.W.M., Le Dévédec S.E. & Water B. van de (2021), Differential reprogramming of breast cancer subtypes in 3D cultures and implications for sensitivity to targeted therapy, Scientific Reports 11: 7529.
- Koedoot E., Wolters L., Water B. van de & Dévédec S.E.L. (2019), Splicing regulatory factors in breast cancer hallmarks and disease progression, Oncotarget 10(57): 6021-6037.
- Bischoff L.J.M., Kuijper I.A., Schimming J.P., Wolters L., Braak B. ter, Langenberg J.P., Noort D., Beltman J.B. & Water B. van de (2019), A systematic analysis of Nrf2 pathway activation dynamics during repeated xenobiotic exposure, Archives of Toxicology 93(2): 435-451.
No relevant ancillary activities